Press Release iMatrix-221

PRESS RELEASE: Successfully Seeding a Broken Heart – Heartseed Inc. succeeds in first human dosing of cardiomyocyte spheroids derived from allogeneic iPS Cells in PhⅠ/Ⅱ clinical trial for advanced heart failure utilizing iMatrix™ family of products. Heartseed Inc, announced that Heartseed successfully dosed the first patient with HS-001, an investigational iPS cell derived therapy for […]